# A Study in the Treatment of Children and Adolescents With Major Depressive Disorder

> **NCT00849693** · PHASE3 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 463 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Placebo
- **DRUG:** fluoxetine
- **DRUG:** duloxetine
- **DRUG:** duloxetine

## Key facts

- **NCT ID:** NCT00849693
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2011-02
- **Final completion:** 2011-09
- **Target enrollment:** 463 (ACTUAL)
- **Last updated:** 2012-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00849693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00849693, "A Study in the Treatment of Children and Adolescents With Major Depressive Disorder". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00849693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*